A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT01178086 · COMPLETED

Trial details

NCT number: NCT01178086
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Lymphocytic Leukemia, Chronic

Start date: 2010-02-22
Primary completion: 2015-06-30
Enrollment: 681

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.